US-listed Chinese stocks are trading higher ahead of China's key policy meeting in the upcoming week, as investors anticipate more stimulus measures to drive the economy and beat potential US tariffs.
As previously reported, UBS analyst Paul Gong downgraded XPeng (XPEV) to Sell from Neutral with a price target of $8.80, up from $8.20. The share price has risen over 50% since September as the newly ...